Back to search

University of British Columbia

Cholesterol catabolism in mycobacterium tuberculosis : studies in pathogenesis, regulation, and metabolic toxicity

Abstract

dc:description

Tuberculosis (TB), a disease caused by the airborne bacterial pathogen Mycobacterium tuberculosis (Mtb) claims the lives of ~1.3 million people every year. Control of Mtb has been hindered by the inefficiency of the current treatment for the disease, which involves several months on a multi-drug regimen with extensive side-effects. The ability of Mtb to enter a state of metabolic quiescence further complicates the development of antimycobacterial agents. During infection, Mtb relies on host-produced cholesterol as a source of carbon and energy. The essentiality of cholesterol catabolism for Mtb during infection has been repeatedly demonstrated and the pathway has thus emerged as a potential target for the development of new TB therapeutics. Catabolism of the cholesterol sidechain and rings A/B leads to the production of propionyl-CoA, pyruvate, and the rings C/D containing metabolite 3aα-H-4α(3'-propanoate)-7aβ-methylhexahydro-1,5-indanedione (HIP). Many of the enzymatic steps involved in the degradation of HIP yield CoA thioester metabolites, the accumulation of which have been shown to cause cholesterol-mediated toxicity in deletion mutants. The findings presented in Chapter 3.1 demonstrate that HIP catabolism is important for the pathogenesis of Mtb and that the cholesterol catabolic pathway is a valid drug target. Chapter 3.2 reveals a novel mechanism involved in the regulation of HIP catabolism in which the first enzyme in its catabolism is reversibly acetylated. In Chapter 3.3, I have shown that deletion of certain HIP catabolizing enzymes leads to the accumulation of cholesterol-derived CoA thioesters, sequestration and depletion of free CoA resulting in a toxic phenotype. These findings suggest that HIP catabolizing enzymes are intriguing candidates for the development of novel TB antibiotics. Together, these data build on previous studies and provide additional insights into cholesterol catabolism in Mtb.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy - PhD
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Microbiology and Immunology
Grantor dc:publisher
University of British Columbia
Year dc:date
2019

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Kirstin, Brown Lee

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/73243

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Kirstin, Brown Lee. Cholesterol catabolism in mycobacterium tuberculosis : studies in pathogenesis, regulation, and metabolic toxicity. doctoral thesis, University of British Columbia, 2019. http://hdl.handle.net/2429/73243